News
In a bid to rework the controversial relationship between drugmakers and patient charities, Regeneron Pharmaceuticals has announced a new program in which it will match up to $200 million in ...
In a bid to rework the controversial relationship between drugmakers and patient charities, Regeneron Pharmaceuticals has announced a new program in which it will match up to $200 million in ...
Oct 4 - Biotech company Regeneron Pharmaceuticals (REGN.O), opens new tab lost a bid on Friday to be held immune from allegations that it misused a patented protein while testing a COVID-19 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results